Evidence map›Paper›PMID 39229108›Full record

ArticlebioRxiv : the preprint server for biology2024

High throughput mutational scanning of a protein via alchemistry on a high-performance computing resource.

Tandac F Guclu, Busra Tayhan, Ebru Cetin, Ali Rana Atilgan, Canan Atilgan

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tandac F GucluFaculty of Natural Sciences and Engineering, Sabanci University, Tuzla, 34956, Istanbul, Turkey.ORCID 0000-0002-2516-1922
Busra TayhanFaculty of Natural Sciences and Engineering, Sabanci University, Tuzla, 34956, Istanbul, Turkey.ORCID 0009-0004-6388-4170
Ebru CetinFaculty of Natural Sciences and Engineering, Sabanci University, Tuzla, 34956, Istanbul, Turkey.ORCID 0000-0001-7355-8345
Ali Rana AtilganFaculty of Natural Sciences and Engineering, Sabanci University, Tuzla, 34956, Istanbul, Turkey.ORCID 0000-0003-0604-6301
Canan AtilganFaculty of Natural Sciences and Engineering, Sabanci University, Tuzla, 34956, Istanbul, Turkey.ORCID 0000-0003-0557-6044

Funding

Mapping epistatic interactions in molecular evolution of antibiotic resistanceR01GM125748 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI Erdal Toprak · 2018 to 2026
$3.6M
NIGMS NIH HHS R01 GM125748
6 · The paper itself

Abstract

Antibiotic resistance presents a significant challenge to public health, as bacteria can develop resistance to antibiotics through random mutations during their life cycles, making the drugs ineffective. Understanding how these mutations contribute to drug resistance at the molecular level is crucial for designing new treatment approaches. Recent advancements in molecular biology tools have made it possible to conduct comprehensive analyses of protein mutations. Computational methods for assessing molecular fitness, such as binding energies, are not as precise as experimental techniques like deep mutational scanning. Although full atomistic alchemical free energy calculations offer the necessary precision, they are seldom used to assess high throughput data as they require significantly more computational resources. We generated a computational library using deep mutational scanning for dihydrofolate reductase (DHFR), a protein commonly studied in antibiotic resistance research. Due to resource limitations, we analyzed 33 out of 159 positions, identifying 16 single amino acid replacements. Calculations were conducted for DHFR in its drug-free state and in the presence of two different inhibitors. We demonstrate the feasibility of such calculations, made possible due to the enhancements in computational resources and their optimized use.

Indexed as

4’-deoxy trimethoprimbacterial fitnessdihydrofolate reductasefree energy perturbationrelative bindingtrimethoprim

Identifiers

PMID39229108
PMCPMC11370492

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.